statistiche ricercatore

Continente	#
EU - Europa	632
NA - Nord America	528
AS - Asia	358
AF - Africa	10
SA - Sud America	6
OC - Oceania	5
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.540

Nazione	#
US - Stati Uniti d'America	520
CN - Cina	243
GB - Regno Unito	209
IT - Italia	156
SE - Svezia	92
DE - Germania	80
JP - Giappone	25
IN - India	23
IE - Irlanda	19
TR - Turchia	15
FI - Finlandia	14
KR - Corea	14
SG - Singapore	14
HK - Hong Kong	12
ES - Italia	11
FR - Francia	11
UA - Ucraina	10
CA - Canada	7
NL - Olanda	7
TW - Taiwan	7
AU - Australia	5
DK - Danimarca	4
EG - Egitto	4
BE - Belgio	3
BR - Brasile	3
CH - Svizzera	3
ET - Etiopia	3
PL - Polonia	3
RO - Romania	3
RU - Federazione Russa	3
AT - Austria	2
EU - Europa	2
IR - Iran	2
RW - Ruanda	2
A2 - ???statistics.table.value.countryCode.A2???	1
AR - Argentina	1
CO - Colombia	1
GR - Grecia	1
HU - Ungheria	1
ID - Indonesia	1
MX - Messico	1
PE - Perù	1
PH - Filippine	1
SA - Arabia Saudita	1
SC - Seychelles	1
Totale	1.542

Nome	#
FGF trapping inhibits multiple myeloma growth through c-Myc degradation-induced mitochondrial oxidative stress	468
PRECLINICAL RATIONALE FOR THE USE OF THE AKT INHIBITOR PERIFOSINE IN COMBINATION WITH THE MULTIKINASE INHIBITOR SORAFENIB IN HODGKIN LYMPHOMA	247
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells	174
Targeting TRAIL Receptors with Genetically-Engineered CD34+ Hematopoietic Stem Cells	143
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma	123
DOT1L-mediated H3K79me2 modification critically regulates gene expression during cardiomyocyte differentiation	97
BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts	87
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts	79
Autophagy as a pathogenic mechanism and drug target in lymphoproliferative disorders	74
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34+ cells	71
Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies	70
Totale	1.633

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	27	0	0	0	0	0	0	0	0	0	0	14	13
2019/2020	151	19	8	5	11	8	20	13	8	27	21	4	7
2020/2021	278	26	23	15	16	29	23	25	22	41	21	29	8
2021/2022	221	12	5	3	13	23	12	7	17	32	34	16	47
2022/2023	278	28	36	19	23	28	49	10	12	35	9	12	17
2023/2024	204	10	16	28	18	51	13	16	29	9	14	0	0
Totale													1.633

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca